Novoeight recombinant and Rucaparib Camsylate
Determining the interaction of Novoeight recombinant and Rucaparib Camsylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
Generic Name: rucaparib
Brand name: Rubraca
Synonyms: Rucaparib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Novoeight recombinant-Ruconest
- Novoeight recombinant-Rufinamide
- Novoeight recombinant-Rufinamide Oral Suspension
- Novoeight recombinant-Rufinamide Tablets
- Novoeight recombinant-Rulox
- Novoeight recombinant-Rum-K
- Rucaparib Camsylate-Novolin 70/30
- Rucaparib Camsylate-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Rucaparib Camsylate-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Rucaparib Camsylate-Novolin N
- Rucaparib Camsylate-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Rucaparib Camsylate-Novolin N (Insulin NPH (Vials))